002001.SZ · 新 和 成
China A-shares · RS rating 49 · As of 2026-10-14
| Price | 25.89 CNY |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 66 / 33 / 78 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 21 / 12 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +8.6% |
| Distance from 52-week high | +34.1% |
| Market cap (USD) | $12.2B |